Martin Larsson

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: BRITISH JOURNAL OF PHARMACOLOGY. 2022;179(4):677-694
Normalisation of glucose metabolism by exendin-4 in the chronic phase after stroke promotes functional recovery in male diabetic mice
Augestad IL; Dekens D; Karampatsi D; Elabi O; Zabala A; Pintana H; Larsson M; Nystrom T; Paul G; Darsalia V; Patrone C
Article: DIABETES. 2020;69(9):1961-1973
Regulation of Glycemia in the Recovery Phase After Stroke Counteracts the Detrimental Effect of Obesity-Induced Type 2 Diabetes on Neurological Recovery
Augestad IL; Pintana H; Larsson M; Krizhanovskii C; Nystrom T; Klein T; Darsalia V; Patrone C
Article: ACTA NEUROLOGICA SCANDINAVICA. 2019;140(6):443-448
Prehospital exenatide in hyperglycemic stroke-A randomized trial
Larsson M; Castren M; Lindstrom V; von Euler M; Patrone C; Wahlgren N; Nathanson D
Article: CARDIOVASCULAR DIABETOLOGY. 2019;18(1):91
GLP-1 secretion in acute ischemic stroke: association with functional outcome and comparison with healthy individuals
Larsson M; Patrone C; von Euler M; Holst JJ; Nathanson D
Article: BMJ OPEN. 2017;7(10):e016311
Safety of thrombolysis in stroke mimics: an observational cohort study from an urban teaching hospital in Sweden
Kostulas N; Larsson M; Kall T-B; von Euler M; Nathanson D
Article: BIOSCIENCE REPORTS. 2016;36(6):e00421
Diabetes negatively affects cortical and striatal GABAergic neurons: an effect that is partially counteracted by exendin-4
Larsson M; Lietzau G; Nathanson D; Ostenson C-G; Mallard C; Johansson ME; Nystrom T; Patrone C; Darsalia V
Article: DIABETES OBESITY & METABOLISM. 2016;18(5):537-541
Gliptin-mediated neuroprotection against stroke requires chronic pretreatment and is independent of glucagon-like peptide-1 receptor
Darsalia V; Larsson M; Lietzau G; Nathanson D; Nystrom T; Klein T; Patrone C
Article: PLOS ONE. 2014;9(8):e103114
Exendin-4 Reduces Ischemic Brain Injury in Normal and Aged Type 2 Diabetic Mice and Promotes Microglial M2 Polarization
Darsalia V; Hua S; Larsson M; Mallard C; Nathanson D; Nystroem T; Sjoeholm A; Johansson ME; Patrone C
Article: REGULATORY PEPTIDES. 2014;190:25-31
Linagliptin enhances neural stem cell proliferation after stroke in type 2 diabetic mice
Darsalia V; Olverling A; Larsson M; Mansouri S; Nathanson D; Nystrom T; Klein T; Sjoholm A; Patrone C
Article: JOURNAL OF CLINICAL MICROBIOLOGY. 2010;48(10):3810-3812
Polymicrobial Bloodstream Infection with Eggerthella lenta and Desulfovibrio desulfuricans
Liderot K; Larsson M; Borang S; Ozenci V

Alla övriga publikationer

Doctoral thesis: 2019
Save the brain! Studies on GLP-1-mediated neuroprotection
Larsson M
Corrigendum: DIABETES OBESITY & METABOLISM. 2018;20(4):1086
Gliptin-mediated neuroprotection against stroke requires chronic pretreatment and is independent of glucagon-like peptide-1 receptor (vol 18, pg 537, 2016)
Darsalia V; Larsson M; Lietzau G; Nathanson D; Nystrom T; Klein T; Patrone C
Editorial comment: CARDIOVASCULAR DIABETOLOGY. 2018;17(1):32
The high need for trials assessing functional outcome after stroke rather than stroke prevention with GLP-1 agonists and DPP-4 inhibitors
Darsalia V; Larsson M; Klein T; Patrone C
Review: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2015;35(5):718-723
Glucagon-like receptor 1 agonists and DPP-4 inhibitors: potential therapies for the treatment of stroke
Darsalia V; Larsson M; Nathanson D; Klein T; Nystrom T; Patrone C

Anställningar

Anknuten till Forskning, Molekylär medicin och kirurgi, Karolinska Institutet, 2023-2026

Examina och utbildning

Medicine Doktorsexamen, Institutionen för klinisk forskning o utbildning, Södersjukhuset, Karolinska Institutet, 2019
Läkarexamen, Karolinska Institutet, 2006

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI